Buchumschlag

Editorial: Vibrating capsule for severe chronic idiopathic constipation—Severity lies in the eye of the beholder

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Sanskriti Varma, Kyle Staller
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Alimentary Pharmacology & Therapeutics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Letter: Irritable bowel syndrome and antibiotics—Authors' reply
von: Kyle Staller, et al.
Veröffentlicht: (2024)

Research Communication: Healthcare Utilisation Patterns in Patients With Irritable Bowel Syndrome Across an Integrated Healthcare System
von: Neil S. Zheng, et al.
Veröffentlicht: (2025)

Editorial: The unquenchable thirst for drinks and diets as treatments for constipation
von: Yoav Mazor, et al.
Veröffentlicht: (2024)

Editorial: Sonographic assessment of colonic content—A new tool for constipation?
von: Giovanni Maconi, et al.
Veröffentlicht: (2024)

Editorial: Sonographic assessment of colonic content—A new tool for constipation? Authors' reply
von: R. M. Mathias, et al.
Veröffentlicht: (2024)

Testing in functional constipation—What's new and what works
von: Leonel Rodriguez
Veröffentlicht: (2024)

Maladaptive weight control and eating behaviours in female adolescents/young adults are associated with increased risk of irritable bowel syndrome in adulthood: Results from the Growing Up Today Study (GUTS)
von: Keming Yang, et al.
Veröffentlicht: (2024)

Meta‐analysis: Intestinal ultrasound to evaluate colonic contents and constipation
von: R. M. Mathias, et al.
Veröffentlicht: (2024)

Editorial: Good Vibrations for Better Colonoscopy Preparation and Constipation
von: Benjamin Kalivas, et al.
Veröffentlicht: (2025)

Editorial: Sequencing rescue therapy for acute severe ulcerative colitis—Ready for revision?
von: L. A. A. P. Derikx, et al.
Veröffentlicht: (2024)

Higher end‐of‐treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg‐negative chronic hepatitis B patients stopping antivirals
von: Yen‐Chun Liu, et al.
Veröffentlicht: (2024)

Editorial: Sequencing rescue therapy for acute severe ulcerative colitis—Ready for revision? Authors' reply
von: María José García, et al.
Veröffentlicht: (2024)

Editorial: ARFI‐based techniques are better than VCTE for diagnosing advanced fibrosis in severe obesity
von: Davide Roccarina, et al.
Veröffentlicht: (2024)

Editorial: Cholestasis Is an Important Marker for Evaluating Clinical Outcomes and Prognosis in Severe Burns and Critically Ill Patients
von: Andrew T. Roberts, et al.
Veröffentlicht: (2026)

Editorial: Patient Reported Outcomes Provide Insight Into Disease Severity for People Living With Primary Sclerosing Cholangitis
von: Aisha Alawi, et al.
Veröffentlicht: (2025)

Editorial: DoesESWL‐ERCPfor pancreatic duct stone removal change the natural course of symptomatic chronic calcific pancreatitis?
von: Richard Kozarek
Veröffentlicht: (2024)

Editorial: DoesESWL‐ERCPfor pancreatic duct stone removal change the natural course of symptomatic chronic calcific pancreatitis? Authors' reply
von: Yu Liu, et al.
Veröffentlicht: (2024)

Review article: Oesophageal disorders in chronic liver disease
von: Francisco Idalsoaga, et al.
Veröffentlicht: (2024)

Letter: Zinc and selenium—Potential biomarkers for chronic liver disease?
von: Zhuo Li, et al.
Veröffentlicht: (2024)

Letter: Why Assessment of ChILI Severity Accurately Matters?
von: Mar Riveiro‐Barciela, et al.
Veröffentlicht: (2024)

Clinical Trial: Effect of Abdominal Vibration Combined With Walking Exercise Programme on Bowel Preparation in Older Patients With Constipation
von: Yuan‐Yuan Zhang, et al.
Veröffentlicht: (2025)

Letter: Association between chronic kidney disease, hepatitis B and antiviral treatments
von: Chen‐Pi Li, et al.
Veröffentlicht: (2024)

Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B
von: Jian Wang, et al.
Veröffentlicht: (2024)

Prevalence and prognostic value of zinc and selenium deficiency in advanced chronic liver disease
von: Nina Dominik, et al.
Veröffentlicht: (2024)

Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis
von: Mushfiqur R. Siddique, et al.
Veröffentlicht: (2025)

Azathioprine or Tofacitinib as Maintenance Therapy in Corticosteroid‐Responsive Acute Severe Ulcerative Colitis
von: Arshdeep Singh, et al.
Veröffentlicht: (2025)

Letter: Steroid Tapering in Ulcerative Colitis: The Importance of Disease Severity and Maintenance Therapy
von: Rónán O'Connor, et al.
Veröffentlicht: (2026)

Letter: Potential impact of Helicobacter pylori infection on oesophageal disorders in chronic liver disease
von: Jannis Kountouras, et al.
Veröffentlicht: (2024)

Editorial on ‘Early HBcrAg and Anti‐ HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation: A Pooled Analysis of Two Clinical Trials’
von: Ming Chao Tsai, et al.
Veröffentlicht: (2025)

Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver Disease
von: Benedikt Simbrunner, et al.
Veröffentlicht: (2025)

Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B—Author's reply
von: Hyeyeon Hong, et al.
Veröffentlicht: (2024)

Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D
von: Jian Wang, et al.
Veröffentlicht: (2024)

Early ileal resection in Crohn's disease is not associated with severe long‐term outcomes: The ERIC study
von: Nathan Grellier, et al.
Veröffentlicht: (2024)

Letter: Refining Mortality Estimates in Severe Alcohol‐Associated Hepatitis—Addressing Heterogeneity and Prognostic Assessment
von: Shupeng Zhao, et al.
Veröffentlicht: (2025)

Letter: Potential impact ofHelicobacter pyloriinfection on oesophageal disorders in chronic liver disease—Authors' reply
von: Francisco Idalsoaga, et al.
Veröffentlicht: (2024)

Letter: ‘Early Ileal Resection in Crohn's Disease Is Not Associated With Severe Long‐Term Outcomes: The ERIC Study’
von: Matthias Kelm, et al.
Veröffentlicht: (2025)

Letter on ‘Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis’—Authors' Reply
von: Francisco Idalsoaga, et al.
Veröffentlicht: (2025)

Letter: Baseline age on antiviral treatment may significantly influence the clinical response of children with chronic hepatitis B
von: Jing Li, et al.
Veröffentlicht: (2024)

Letter: Third‐line therapy in acute severe ulcerative colitis, exploring the uncertainty and unanswered questions—Authors' reply
von: María José García, et al.
Veröffentlicht: (2024)

Systematic review with meta‐analysis: Steatosis severity and subclinical atherosclerosis in metabolic dysfunction‐associated steatotic liver disease
von: Mohamad Jamalinia, et al.
Veröffentlicht: (2024)